Schernthaner G, Groop PH, Kalra PA, Ronco C, et al. SGLT-2 Inhibitor Renal Outcome Modification in Type-2 Diabetes: Evidence from Studies in Patients with High or Low Renal Risk. Diabetes Obes Metab 2020 Feb 9. doi: 10.1111/dom.13994.
PMID: 32037647